Abstract:O-linked conjugation of ß-N-acetyl-glucosamine (O-GlcNAc) to serine and threonine residues is a post-translational modification process that senses nutrient availability and cellular stress and regulates diverse biological processes that are involved in neurodegenerative diseases and provide potential targets for therapeutics development. However, very little is known of the networks involved in the brain that are responsive to changes in the O-GlcNAc proteome. Pharmacological increase of protein O-GlcNAcylation by Thiamet G (TG) has been shown to decrease tau phosphorylation and neurotoxicity, and proposed as a therapy in Alzheimer's disease (AD). However, acute TG exposure impairs learning and memory, and protein O-GlcNAcylation is increased in the aging rat brain and in Parkinson's disease (PD) brains. To define the cortical O-GlcNAc proteome that responds to TG, we injected young adult mice with either saline or TG and performed mass spectrometry analysis for detection of O-GlcNAcylated peptides. This approach identified 506 unique peptides corresponding to 278 proteins that are O-GlcNAcylated. Of the 506 unique peptides, 85 peptides are elevated by > 1.5 fold in O-GlcNAcylation levels in response to TG. Using pathway analyses, we found TG-dependent enrichment of O-GlcNAcylated synaptic proteins, trafficking, Notch/Wnt signaling, HDAC signaling, and circadian clock proteins. Significant changes in the O-GlcNAcylation of DNAJC6/AUXI, and PICALM, proteins that are risk factors for PD and/or AD respectively, were detected. We compared our study with two key prior O-GlcNAc proteome studies using mouse cerebral tissue and human AD brains. Among those identified to be increased by TG, 15 are also identified to be increased in human AD brains compared to control, including those involved in cytoskeleton, autophagy, chromatin organization and mitochondrial dysfunction. These studies provide insights regarding neurodegenerative diseases therapeutic targets.

Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability

An intellectual disability syndrome with single-nucleotide variants in O-GlcNAc transferase

Genetic gradual reduction of OGT activity unveils the essential role of O-GlcNAc in the mouse embryo

Neuronal loss of Impairs O-glycosylation and Leads to Neurobehavioral Deficits Mimicking GALNT2-CDG

Neuroectoderm phenotypes in a human stem cell model of O-GlcNAc transferase associated with intellectual disability

Thiamme2-G, a Novel O-GlcNAcase Inhibitor, Reduces Tau Hyperphosphorylation and Rescues Cognitive Impairment in Mice

O-GlcNAcylation of the intellectual disability protein DDX3X exerts proteostatic cell cycle control

Loss of O-GlcNAc transferase in neural stem cells impairs corticogenesis

Ogt Deficiency Induces Abnormal Cerebellar Function and Behavioral Deficits of Adult Mice through Modulating RhoA/ROCK Signaling

Ogt controls neural stem/progenitor cell pool and adult neurogenesis through modulating Notch signaling

The Role of O-GlcNAcation in Neurodevelopment and Nerve System Diseases

Defining the Dynamic Regulation of O-GlcNAc Proteome in the Mouse Cortex---the O-GlcNAcylation of Synaptic and Trafficking Proteins Related to Neurodegenerative Diseases

A Mutant Bacterial O-GlcNAcase Visualizes a Progressive Decline of Protein O-GlcNAcylation in Early Drosophila Embryos Critical for Neurodevelopment

Glutaminase C Overexpression in the Brain Induces Learning Deficits, Synaptic Dysfunctions, and Neuroinflammation in Mice.

Genetic modeling of GNAO1 disorder delineates mechanisms of Go dysfunction

Systemic or Forebrain Neuron-Specific Deficiency of Geranylgeranyltransferase-1 Impairs Synaptic Plasticity and Reduces Dendritic Spine Density

Protein O-GlcNAcylation Homeostasis Regulates Facultative Heterochromatin to Fine-Tune Sog-Dpp Signaling During Drosophila Early Embryogenesis.

Deep postnatal phenotyping of a new mouse model of nonketotic hyperglycinemia

Compound heterozygous mutations of NTNG2 cause intellectual disability via inhibition of the CaMKII signaling

Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway

O-GlcNAc Transferase Ogt Regulates Embryonic Neuronal Development Through Modulating Wnt/β-catenin Signaling